Rentokil Initial Plc /Fi (RKLIF) EBT (2021 - 2025)

Rentokil Initial (RKLIF) has reported EBT for 4 consecutive years, with $318.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, EBT changed N/A year-over-year to $318.0 million; the TTM figure through Dec 2025 stood at $988.3 million (changed N/A YoY), while the FY2025 annual figure was $390.0 million, down 15.58% from the prior year.
• EBT climbed to $318.0 million in Q4 2025 per RKLIF's latest filing, from -$144.0 million in the prior quarter.
• Across five years, EBT topped out at $645.7 million in Q4 2021 and bottomed at -$144.0 million in Q3 2025.
• Historically, EBT has averaged $326.8 million across 4 years, with a median of $318.0 million in 2025.
• Annual changes were most pronounced in 2022 — EBT tumbled 70.57% — and 2023, when it surged 228.55%.
• Rentokil Initial's EBT stood at $645.7 million in 2021, then sank by 70.57% to $190.0 million in 2022, then soared by 228.55% to $624.3 million in 2023, then sank by 49.06% to $318.0 million in 2025.
• Business Quant data shows RKLIF's EBT at $318.0 million in Q4 2025, -$144.0 million in Q3 2025, and $624.3 million in Q4 2023.